Overview Press Releases Events and Presentations Financials and Filings Stock Information Corporate Governance FAQs Madrigal press releases are available below. Search them by keyword or browse by date. Year None2022202120202019201820172016 January 30, 2022 Madrigal Pharmaceuticals To Announce Topline Results from the Phase 3 MAESTRO-NAFLD-1 Study of Resmetirom on Monday, January 31st January 10, 2022 Dominic F. Labriola Joins Madrigal Pharmaceuticals as Chief Data and Analytics Officer Pagination Previous page Page 1 Current page 2
Madrigal press releases are available below. Search them by keyword or browse by date. Year None2022202120202019201820172016 January 30, 2022 Madrigal Pharmaceuticals To Announce Topline Results from the Phase 3 MAESTRO-NAFLD-1 Study of Resmetirom on Monday, January 31st January 10, 2022 Dominic F. Labriola Joins Madrigal Pharmaceuticals as Chief Data and Analytics Officer Pagination Previous page Page 1 Current page 2
January 30, 2022 Madrigal Pharmaceuticals To Announce Topline Results from the Phase 3 MAESTRO-NAFLD-1 Study of Resmetirom on Monday, January 31st
January 10, 2022 Dominic F. Labriola Joins Madrigal Pharmaceuticals as Chief Data and Analytics Officer
